Na Xu
Impact in
-
- Acute Myocardial Infarction Research
-
- Hepatitis C virus research
Papers in
-
- Acute Myocardial Infarction Research 6
- Co-authors
- Tomáš Roubíček (2 shared papers)Vesna D. Garovic (1 shared paper)Anthony W. Stanson (1 shared paper)Garvan C. Kane (1 shared paper)Bo Xu (4 shared papers)Xiaofang Tang (6 shared papers)Yi Yao (4 shared papers)Baisong Zheng (1 shared paper)
- Journals
- Medicine (4 papers)Frontiers in Oncology (2 papers)Cancer (1 paper)Scientific Reports (1 paper)Infection and Drug Resistance (1 paper)
- Partner nations
- ChinaUnited StatesAustralia
In The Last Decade
Na Xu
40 papers receiving 441 citations
Peers
Comparison fields: 5 of 78
- Cardiology and Cardiovascular Medicine 116
- Hepatology 35
- Obstetrics and Gynecology 30
- Pulmonary and Respiratory Medicine 110
- Physiology 14
Countries citing papers authored by Na Xu
This map shows the geographic impact of Na Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Na Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Na Xu more than expected).
Fields of papers citing papers by Na Xu
This network shows the impact of papers produced by Na Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Na Xu. The network helps show where Na Xu may publish in the future.
Co-authors
The 25 scholars most cited alongside Na Xu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 44 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2009 | 80 | |
| 2 | 2020 | 46 | |
| 3 | 2018 | 40 | |
| 4 | 2023 | 34 | |
| 5 | 2016 | 33 | |
| 6 | 2019 | 32 | |
| 7 | 2018 | 28 | |
| 8 | 2015 | 15 | |
| 9 | Lunar phases, myocardial infarction and hemorrheological character. A Western medical study combined with appraisal of the related traditional Chinese medical theory. | 1989 | 14 |
| 10 | 2014 | 12 | |
| 11 | 2021 | 11 | |
| 12 | 2019 | 10 | |
| 13 | 2019 | 9 | |
| 14 | 2018 | 9 | |
| 15 | 2020 | 8 | |
| 16 | 2021 | 7 | |
| 17 | 2022 | 6 | |
| 18 | 2023 | 5 | |
| 19 | 2010 | 5 | |
| 20 | 2019 | 5 |
About Na Xu
Na Xu is a scholar working on Cardiology and Cardiovascular Medicine, Pulmonary and Respiratory Medicine, Surgery, Oncology and Rheumatology, having authored 44 papers that have together received 452 indexed citations. Recurring topics across this work include Acute Myocardial Infarction Research (6 papers), Gout, Hyperuricemia, Uric Acid (5 papers), Immune Cell Function and Interaction (3 papers), Coronary Interventions and Diagnostics (3 papers), HIV/AIDS Research and Interventions (2 papers), Inflammatory Biomarkers in Disease Prognosis (2 papers), Advanced X-ray and CT Imaging (2 papers) and Autoimmune and Inflammatory Disorders Research (2 papers). The work is most often cited by research in Cardiology and Cardiovascular Medicine (116 citations), Hepatology (35 citations), Obstetrics and Gynecology (30 citations), Pulmonary and Respiratory Medicine (110 citations) and Physiology (14 citations). Na Xu has collaborated with scholars based in China, United States and Australia. Frequent co-authors include Tomáš Roubíček, Vesna D. Garovic, Anthony W. Stanson, Garvan C. Kane, Bo Xu, Xiaofang Tang, Yi Yao, Baisong Zheng, Wenyan Zhang and Chen Huan. Their work appears in journals such as Medicine, Frontiers in Oncology, Cancer, Scientific Reports and Infection and Drug Resistance.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.